A Study to Investigate the Influence of MK0859 on Blood Pressure
This study will investigate the influence of MK0859 on ambulatory blood pressure, and how safe and tolerable MK0859 is on the subjects This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).
Please refer to this study by its ClinicalTrials.gov identifier: NCT00565006
|Study Director:||Medical Monitor||Merck Sharp & Dohme Corp.|